Granules India informs about company updates

29 Oct 2018 Evaluate

Granules India has informed that Granules Pharmaceuticals Inc. Completed U.S. FDA inspection from 22nd October 2018 to 26th October 2018 with two Form 483 observations. Granules Pharmaceuticals, Inc. will respond to the observations within this week. This was a prior approval inspection, intended for the ANDAs filed by Granules Pharmaceuticals, Inc. This facility is involved in development and manufacturing of Finished Dosages.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

578.80 13.85 (2.45%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×